Human Dignity and Harm Reduction

Slides:



Advertisements
Similar presentations
Daliah Heller, PhD, MPH Assistant Commissioner
Advertisements

Sharon Stancliff, MD Caroline Rath, PA-C Harm Reduction Coalition New York, NY USA.
Meeting need and improving coverage workshop. Meeting need: calculating and improving coverage.
Harm Reduction for Young People: Why A Youth Network? Diane Riley, PhD Canadian Foundation for Drug Policy, Youth Network for Harm Reduction & University.
Strategies and Interventions for Community-Based Organizations Implementing HIV Prevention Joseph Prejean, Ph. D. Capacity Building Branch Division of.
North Carolina Harm Reduction Coalition. North Carolina Harm Reduction Coalition (NCHRC) is North Carolina’s only comprehensive harm reduction program.
Harm Reduction Principles in Practice Part 1 of 3 What does H.R. actually mean? We will look at H.R. philosophy + how to incorporate it into informal and.
CASE STUDIES OF PUBLIC HEALTH RESEARCH THAT HAVE ALTERED PUBLIC POLICY THE NEW HAVEN SEP EVALUATION.
Models of Harm Reduction
HIV and Hepatitis C in non- MSM Rural Communities: Issues and Interventions Shari Wells-Weiss, CASAC Director of Prevention Services Southern Tier AIDS.
“Humanitarian Action” The Saint-Petersburg Charitable Foundation for Medical and Social Programs HAF.
Copyright Alcohol Medical Scholars Program 1 Opioid Agonist Treatment: “Trading one substance for another?” Joseph Sakai, M.D.
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
California Department of Public Health Office of AIDS Access to Sterile Syringes: Changes to California Law Alessandra Ross, MPH InjectionUse Specialist.
Overview of Syringe Exchange Programs New York City Police Academy November 24, 2004.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
HIV and drug prevention in Estonia Harm reduction services
Peterborough Drug Strategy
Strategies for Incorporating OD Prevention Into Your Work Eliza Wheeler Drug Overdose Prevention & Education (DOPE) Project Harm Reduction Coalition
Overview of Harm Reduction and Sterile Syringe Access Anna Benyo Syringe Access Policy Coordinator Harm Reduction Coalition New Jersey Syringe Access Informational.
Working with SEPs: How do we expand Hepatitis Services ? Narelle Ellendon, RN HCV Director Harm Reduction Coalition, NYC
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
Recommendations on the Management of Opioid Overdose Ruth Birgin.
Building Trust With the Injection Drug Community Megan Hatta, RN.
November 2012 Prepared for the Contra Costa Board of Supervisors by Contra Costa Health Department Needle Exchange Update.
HIV/AIDS VACCINE AWARENESS Vaccine 101 Jeremiah Brewer Health and Training Educator African – Americans Reach and Teach Health Ministry.
Washington D.C., USA, July 2012www.aids2012.org Human rights as a key component of harm reduction strategy targeting people using drugs in Morocco.
Quaboag Hills Community Coalition Substance Use Task Force October 20, 2014 Overview of the Strategic Prevention Framework (SPF) “Road Map” What are Evidence-Based.
STD Control Branch Addressing HCV through a Drug User Health Framework NASTAD Viral Hepatitis Technical Assistance Meeting, October 21, 2014 Washington,
Washington D.C., USA, July 2012www.aids2012.org Alternatives to NSEPs: community-based initiatives Providing access to syringes in the politically.
Lydia H. Guterman Consultant, Open Society Institute September 25, 2008 Sofia, Bulgaria Many thanks to the Harm Reduction Coalition for partial content.
Role of harm reduction in HCV prevention in France: from research to scale up Bruno Spire & Patrizia Carrieri.
Pennsylvania: The State of HCV 2015
Injection Drug Use and Hepatitis C What Can We Do About It? Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse.
Harm Reduction Team Maureen Woods Team Leader. Service Delivery Aims Develop harm reduction initiatives in partnership with other agencies to reduce the.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS State of the art and new perspectives in drug addiction treatment Dr L Michel, MD, PhD Inserm U1178.
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
Homelessness and Brain Injury Dave Katzenmeyer, Geoffrey Meyer, Kris Helgeson.
Collaborative Effort of HIV, Domestic Violence and Homeless Service Organizations to Develop Integrated Services as Strategy for HIV Risk Reduction for.
Organizing Drug Users for Public Health Policy Changes 17 th International Conference on the Reduction of Drug Related Harm Jason Farrell, Executive Director.
Bystander Naloxone Training Saves Lives. Death rates are spiraling out of control--for both prescription opioids and heroin! Graphic: Nytimes.com.
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
Deadly trio: mental health – HIV - drugs
Pharmacist Role in Naloxone Prescribing
Name(s) Here Job Title(s) Here.
MODULE 3 Harm reduction advocacy
Hepatitis C Allies of Philadelphia August 2, 2017
COLLECTIVE IMPACT APPROACH TO ADDRESSING
Current harm reduction program at outreach
Addressing Drug Use Together Through a Health Based Approach:
Principles of Harm Reduction
Henry L. Dorkin, MD, FAAP President, Massachusetts Medical Society
Experiences from a national overdose prevention strategy: Nasal naloxone distribution and lessons learned Philipp Lobmaier, MD, PhD Norwegian Centre.
Addiction and the Opioid Crisis: HHS Update
Steve Alsum The Grand Rapids Red Project
Jonathan Mermin, MD, MPH RADM, USPHS
A State Targeted Response to the Opioid Crisis:
Head of Research centre
Tacoma Needle Exchange Tier Based Care Coordination
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Opioid-related harms and responses
There are over 200 syringe access service programs (SSP) in the United States. These programs provide sterile syringes to people who inject drugs and.
Pain Management and Substance Use Disorders: JCPP Strategic Session
ENDING THE EPIDEMICS: A FOCUS ON PEOPLE WHO INJECT DRUGS
State Response to Opioids and Infectious Disease
HAND UP HEALTH SERVICES
Town of Collingwood Council September 10th, 2018 Mia Brown RN BScN
Offender Peer Education in the Texas Department of Criminal Justice
Public/Population Health Approach to Substance Abuse Prevention & Treatment Determine the Burden of Substance Abuse and Service Barriers to Develop Plan.
Addiction Prevention Services
Presentation transcript:

Human Dignity and Harm Reduction

Topics for Today Overview of harm reduction Sterile syringe access programs Preventing fatal opioid overdoses Human Dignity

Human Dignity Means that an individual or group feels self-respected and self- worth. It is concerned with physical and psychological integrity and empowerment.

Working Definition of Harm Reduction Harm reduction is a set of practical public health strategies designed to reduce the negative consequences of drug use and promote healthy individuals and communities.

Key Principles of Harm Reduction Promotes public health interventions that minimize the harmful affects of drug use Understands drug use as a complex, multifaceted issue that encompasses behaviors from severe abuse to total abstinence Meets people where they are in the course of their drug use

Key Principles of Harm Reduction Ensures that people who use drugs have a real voice in the creation of programs Affirms people who use drugs are the primary agents of change Empowers communities to share information and support each other

Social and Environmental Factors Harm reduction does not attempt to minimize the real dangers associated with legal and illegal drug use and how those issues impact our lives.

Harm Reduction Practice Nonjudgmental, noncoercive provision of services Low-threshold program models Resources to people who use drugs

Goals of Harm Reduction Prevent disease: sterile syringe access to prevent HIV and hepatitis Reduce mortality: Fatal overdose prevention with training and naloxone distribution; link to medical care and social services

Goals of Harm Reduction Treatment for drug dependence: buprenorphine, methadone, naltrexone, or suboxone Empower communities and reduce stigma: community organizing and engagement

Harm Reduction Resource http://www.harmreductioncoalition.org

Sterile Syringe Access History and Timeline The first sterile syringe access program started in Holland in response to a hepatitis B outbreak in the 1980s. The first legal program in the United States started in Tacoma, Washington, in 1988.

Sterile Syringe Access History and Timeline The first Wisconsin program began in 1994. This program is rooted in activism and advocacy.

Efficacy and Outcomes Sterile syringe access programs are the most effective evidence-based HIV/hepatitis C (HCV) prevention tool for people who use drugs. At least seven federally funded research studies have been conducted and have found that syringe access programs are a valuable resource.

Efficacy and Outcomes The use of sterile syringes and harm reduction practices has reversed the course of the AIDS epidemic.

Sterile Syringe Access Programs Reduce HIV infection Reduce the risk for HCV infection Link participants to drug treatment, medical care, housing, and other social services

Sterile Syringe Access Programs Do not encourage drug use Do not increase crime rates Do not increase needlestick injuries in the community

Injection Drug Use: National Scope Injection drug use occurs in every socioeconomic and racial or ethnic group and in urban, suburban, and rural areas. The majority of injection drug users are men, but the number of women who inject is on the rise.

Need for Sterile Syringe Access Programs and Harm Reduction Over 8,000 people are newly infected with HIV every year due to syringe sharing. In 2016, 237 people were newly infected with HIV in Wisconsin, including five due to syringe sharing. Over 15,000 people are newly infected with HCV every year due to syringe and equipment sharing.

Sterile Syringe Access Programs Programs in 44 states, Puerto Rico, and Washington D.C. Wisconsin programs provided by the AIDS Resource Center of Wisconsin, 16th Street Community Health Center, and several local health departments Nearly 225 in operation today

Sterile Syringe Access Programs Syringe exchange Over-the-counter pharmacy sales Syringe prescriptions The programs are endorsed by the American Medical Association and American Public Health Association, among many other legal, medical, and policy institutions.

Sterile Syringe Access Program Models Storefront Street-based Peer and secondary exchange through networks Underground, unauthorized programs Street-based… (fixed sites; roving sites through vans and/or walking teams)

Essential Materials Syringes or needles Cookers Cotton Alcohol wipes Antibiotic ointment Tourniquets

Preventing Fatal Opioid Overdose A majority of overdoses (85%) are witnessed. Naloxone reverses an opioid overdose. Active drug users respond

How to Respond to an Overdose Stimulate: Can they be awakened? Call 911 Airway Rescue breathing Evaluate Muscular injection of naloxone or nasal spray Evaluate and support

Contact Information Dennis Radloff Human Services Program Coordinator 1 W. Wilson Street – RM 850, Madison WI 53703 608-267-1427 dennis.radloff@wisconsin.gov